Coronavirus Update - 09th November 2020

We would like to reassure our customers that as England enters its second national lockdown period, we remain open for business and at full capacity as we have done since the start of this pandemic and fully comply with all government guidance on minimising the risks of COVID-19.

As the situation continues to evolve, we will keep all our customers and stakeholders informed of our activities through this web-page which is updated on a regular basis.

Formulation Development

We combine formulation development with physical characterisation and analytical method development. The team works together to determine how best to formulate APIs for both non-clinical and clinical applications. We have the flexibility to overcome challenges in development processes seamlessly, delivering speed alongside increased quality.